Home/Filings/4/0001555280-22-000118
4//SEC Filing

Trawicki Roman 4

Accession 0001555280-22-000118

CIK 0001555280other

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 4:38 PM ET

Size

9.1 KB

Accession

0001555280-22-000118

Insider Transaction Report

Form 4
Period: 2022-03-16
Trawicki Roman
Executive Vice President
Transactions
  • Exercise/Conversion

    Common Stock

    2022-03-16$87.51/sh+6,000$525,06014,218 total
  • Sale

    Common Stock

    2022-03-16$188.15/sh6,000$1,128,9008,218 total
  • Exercise/Conversion

    Stock Option

    2022-03-166,00033,941 total
    Common Stock (6,000 underlying)
Footnotes (6)
  • [F1]The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.10 to $188.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
  • [F3]6,000 options granted February 12, 2019 at an exercise price of $87.51 per option.
  • [F4]Each option vests on the third anniversary of the date of grant.
  • [F5]Each option expires on the tenth anniversary of the date of grant.
  • [F6]7,774 options granted February 12, 2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; 9,254 options granted February 10, 2021 at an exercise price of $160.62 per option; and 7,332 options granted February 8, 2022 at an exercise price of $201.30 per option.

Issuer

Zoetis Inc.

CIK 0001555280

Entity typeother

Related Parties

1
  • filerCIK 0001640777

Filing Metadata

Form type
4
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 4:38 PM ET
Size
9.1 KB